We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Final Guidance on Post-Complete Response Letter Meetings
FDA Issues Final Guidance on Post-Complete Response Letter Meetings
The FDA Monday finalized its guidance on post-complete response letter meetings with ANDA applicants, spelling out the criteria for granting or denying meeting requests.